Track topics on Twitter Track topics that are important to you
David SalazarThe Food and Drug Administration has approved a generic of Mikart’s hydrocodone bitartrate and acetaminophen tablets from Gavis Pharmaceuticals, Lupin’s U.S. subsidiary, the c...
Life Sciences Jobs ...
Lupin Somerset's generic version of Allergan Sales' Norco tablets, or hydrocodone bitartrate and acetaminophen, has been appr -More-
* Lupin receives FDA approval for hydrocodone bitartrate and acetaminophen tablets Source text: http://bit.ly/2gk6NWI Further company coverage:
* Teva receives FDA approval for VANTRELATM ER (hydrocodone bitartrate) extended-release tablets formulated with proprietary abuse deterrence technology Source text for Eikon: Further company covera...
How have prescribing patterns for hydrocodone/acetaminophen among veterans changed in recent years? Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health
An extension study shows that patients receiving an investigational abuse-deterrent hydrocodone (Vantrela ER) maintained pain relief for 6 months and that the drug was still safe. Medscape Medical N...
The FDA has issued a warning regarding the combined use of opioids and benzodiazepines, which may result in serious adverse effects such as difficult or slowed breathing and death, according to a pres...
Hydrocodone bitartrate extended-release (Hysingla(®) ER; referred to hereafter as hydrocodone ER) was the first single-entity hydrocodone formulation recognized by the US FDA as having abuse-deterren...
A once-daily, extended-release hydrocodone bitartrate tablet with abuse-deterrent properties (Hysingla ER [HYD]) is available for the treatment of chronic pain in appropriate patients. This study e...
Immediate-release (IR) hydrocodone is the most widely prescribed opioid in the United States; however, little is known about the utilization patterns and duration of opioid use among patients prescrib...
Use/misuse of the opioid combination hydrocodone-acetaminophen has been associated with permanent hearing loss. Although reports have been rare, this potential effect can have significant detrimental ...
The U.S. Drug Enforcement Administration (DEA) rescheduled hydrocodone combination products (HCPs) in an attempt to mitigate the prescription opioid epidemic. Many in the medical and pharmacy communit...